PureTech Health plc (LON:PRTC – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of GBX 123.34 and traded as low as GBX 121.60. PureTech Health shares last traded at GBX 122.20, with a volume of 1,849,151 shares traded.
Wall Street Analyst Weigh In
Separately, Peel Hunt reissued a “buy” rating and issued a GBX 508 target price on shares of PureTech Health in a research note on Monday, July 13th. One research analyst has rated the stock with a Buy rating. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of GBX 508.
View Our Latest Report on PRTC
PureTech Health Price Performance
The company has a debt-to-equity ratio of 4.78, a current ratio of 4.60 and a quick ratio of 2.51. The company has a market cap of £292.74 million, a PE ratio of -2.34 and a beta of 0.77. The company has a 50-day moving average price of GBX 116.99 and a two-hundred day moving average price of GBX 123.27.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.
Further Reading
- Five stocks we like better than PureTech Health
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
